Memorial Sloan Kettering Cancer Center Research Shows How Realyze Intelligence Solves the Scalability Problem of Manual Curation

A poster, presented today, Thursday, April 9, 2024, at the American Association for Cancer Research Annual Meeting, (AACR Annual Meeting) demonstrated that researchers at Memorial Sloan Kettering Cancer Center (MSKCC) successfully applied machine learning (ML) and large language models (LLM) to augment the manual curation of cancer data elements using the Realyze Intelligence platform. 

Realyze Intelligence Named to CancerX Accelerator Inaugural Class

Realyze Intelligence has earned a position among the inaugural class of start-up companies selected for the CancerX Startup Accelerator, part of the Biden administration Cancer Moonshot program that aims to cut the U.S. cancer death rate in half within the next 25 years.

New Report: Optimizing Clinical Trials at Health Systems

Matching patients to clinical trials could be improved with an artificial intelligence (AI) solution that allows health systems to identify participants more quickly and easily, according to new research from the Center for Connected Medicine (CCM). Report available to download.